Literature DB >> 31015239

Simple semi-permanent blockade against rigid varus foot in a case with spasticity: possible practical benefits in ambulatory adults.

Tetsutaro Yahata1, Takahiro Maruta1,2, Aki Nakanami1,3.   

Abstract

A 55-year-old ambulatory woman with hemiplegia and varus foot deformity had several problems in her daily life, including load pain and stance instability in the affected foot, easy fatigue of the non-paralysed leg, low back pain, neck stiffness and rapid shoe-rubber wear on the deformed side. We began repeated focal blockades using botulinum toxin to the tibialis posterior muscle to control varus spasticity. Distant influences presenting in the whole body were relieved soon after the first blockade, and shoe wear also stopped. Although, neither the deformed appearance nor foot contact pattern on walking changed in the initial period after beginning the blockade, the foot contact pattern revealed gradual improvement over several years. Generally, surgical correction is indicated for the treatment of deformed feet. The present case suggests that, in case of varus-deformed foot with some spastic elements, trial of focal blockade for varus spasticity may be worthwhile. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  botulinum toxin; general practice / family medicine; orthopaedics; rehabilitation medicine

Mesh:

Substances:

Year:  2019        PMID: 31015239      PMCID: PMC6510135          DOI: 10.1136/bcr-2018-227732

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Treatment of spasticity with muscle afferent block.

Authors:  T Mezaki; R Kaji; N Hirota; N Kohara; J Kimura
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

2.  Location of the motor entry point and intramuscular motor point of the tibialis posterior muscle: for effective motor point block.

Authors:  Je-Hun Lee; Be-Na Lee; Xiaochun An; Rak-Hee Chung; Seung-Ho Han
Journal:  Clin Anat       Date:  2010-10-29       Impact factor: 2.414

3.  Comparison of phenol and alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle for treatment of spastic foot after stroke: a randomized controlled pilot study.

Authors:  H Kocabas; A Salli; A H Demir; O M Ozerbil
Journal:  Eur J Phys Rehabil Med       Date:  2010-03       Impact factor: 2.874

4.  Short-term effect of botulinum toxin a injection on spastic equinovarus foot in cerebral palsy patients: a study using the foot pressure measurement system.

Authors:  Su Min Son; In Sik Park; Jin Sun Yoo
Journal:  Ann Rehabil Med       Date:  2015-02-28

5.  Outcomes of Botulinum Toxin Type A for equinovarus deformity in patients with CVA: A case series.

Authors:  Priya Karakkattil; Elaine Trudelle-Jackson; Heather Hilliard Brown; Patrick Hammontree; Mary Okolo
Journal:  Physiother Theory Pract       Date:  2017-05-08       Impact factor: 2.279

6.  Split tendon transfers for the correction of spastic varus foot deformity: a case series study.

Authors:  Maria Vlachou; Dimitris Dimitriadis
Journal:  J Foot Ankle Res       Date:  2010-12-14       Impact factor: 2.303

7.  Assessment and treatment of spastic equinovarus foot after stroke: Guidance from the Mont-Godinne interdisciplinary group.

Authors:  Thierry Deltombe; Delphine Wautier; Philippe De Cloedt; Michèle Fostier; Thierry Gustin
Journal:  J Rehabil Med       Date:  2017-06-28       Impact factor: 2.912

Review 8.  Overview of foot deformity management in children with cerebral palsy.

Authors:  Julieanne P Sees; Freeman Miller
Journal:  J Child Orthop       Date:  2013-09-14       Impact factor: 1.548

9.  [Epidemiology of pes varus and/or equinus one year after a first cerebral hemisphere stroke: apropos of a cohort of 86 patients].

Authors:  C Verdié; J C Daviet; M J Borie; S Popielarz; M Munoz; J Y Salle; I Rebeyrotte; P Dudognon
Journal:  Ann Readapt Med Phys       Date:  2004-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.